Bristol Myers Squibb Co. Stock Rises Tuesday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) inched 0.71% higher to $66.47 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.68% to 3,920.56 and the Dow Jones Industrial Average rising 1.06% to 32,155.40. This was the stock's second consecutive day of gains. Bristol Myers Squibb Co. closed $14.97 short of its 52-week high ($81.44), which the company reached on December 1st.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.56% to $153.92, Pfizer Inc. (PFE) rose 0.10% to $39.90, and Abbott Laboratories (ABT) rose 0.37% to $98.55. Trading volume (9.2 M) eclipsed its 50-day average volume of 8.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 14, 2023.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 14, 2023 20:34 ET (00:34 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.